Finasteride vs Pembrolizumab

## Finasteride vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Finasteride** and **Pembrolizumab**.

## Mechanism of Action

**Finasteride**: Competitive inhibitor of 5-alpha-reductase type II.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Finasteride — 5-6 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Finasteride — C23H36N2O2; Pembrolizumab — N/A.

**Molecular Weight**: Finasteride — 372.5490 g/mol; Pembrolizumab — N/A.

**Type**: Finasteride — Small molecule; Pembrolizumab — Antibody.